期刊文献+

欧盟药物警戒体系建立运行与实施进展 被引量:16

Establishment and Operation of EU Pharmacovigilance System and Its Implementation Progress
下载PDF
导出
摘要 目的对欧盟药物警戒体系及其实施进展进行介绍,为完善我国药物警戒体系提供参考。方法通过查阅国内外文献,运用文献研究法进行分析。结果在欧盟药物警戒体系内,其法律法规文件完整规范,各相关方职责明确,程序简化合理,信息公开透明,可合理有效的保障药品整个生命周期的安全。结论我国应借鉴欧盟药物警戒体系,提高我国药品安全监测能力。 Objective According to the introduction of EU pharmacovigilance system and its implementation progress, suggestions were put forward to provide the example and reference for perfecting and developing pharmacovigilance system of China. Methods Literature study was used to analyze the foreign and domestic materials. Results Within the EU pharmacovigilance system, there are complete and standard legal documents, clear obligation, simplified and reasonable procedures and public information to effectively guarantee the safety of drugs throughout the life cycle. Conclusion We should learn from EU pharmacovigilance system to improve our ability to monitor drug safety.
作者 宋洋 杨悦
出处 《中国药物警戒》 2014年第7期401-406,共6页 Chinese Journal of Pharmacovigilance
关键词 欧盟 欧洲药品管理局 药物警戒体系 药物警戒法规 EU EMA pharmacovigilance system pharmacovigilance legislation
  • 相关文献

参考文献10

  • 1孙钰.药物警戒的起源、发展与展望[J].药物流行病学杂志,2010,19(8):454-461. 被引量:14
  • 2John-Joseph Borg, George Aislaitner, Michal Pirozynski, et al. A Review of the New EU Legislation on Pharmacovigilance[J]. Drug Saf, 2011,34(3): 187-197.
  • 3European Union. Pharmacovigilance[EB/OL].( 2012-10-04 ) [2013- 12-26]. http://europa, eu/ rapid/ press- release_MEMO-12-737_ en.htm?locale=en.
  • 4European Commision.The EU pharmacovigilance system [EB/OL]. (2013-10-01)[2013-12-26]. http://ec.europa.eu/health/human-use/ pharmacovigilance/index en.htm.
  • 5EMA.Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010[EB/OL].(2010-12-15)[2013-12-26]. http://eur-lex, europa, eu/LexUriServ/LexUriServ, do ?uri=OJ: L : 2010:348:0074:0099:EN:PDF.
  • 6EMA.Annual report 2012 [EB/OL].(2013-07-21 )[2013-12-26]. http://www.ema.europa.eu/docs/en_GB/document_library/Annu- al_report/2013/04/WC500142077.pdf.
  • 7EMA. First Annual Report on EudraVigilance for the European Parliament, the Council and the Commission [EB/OL].(2013-03-21 ) [2013-12-26].http://www.ema.europa.eu/docs/en_GB/document_ library/Report/2013/07/WC500146607.pdf.
  • 8EMA. Regulation(EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010[EB/OL].(2010-12-15) [2013-12-26].http://eur-lex.europa.eu/LexUriServ/LexUriServ.do? uri=OJ:L:2010:348:0001:0016:EN:PDF.
  • 9董铎,吴桂芝,田春华,陈易新,李馨龄,张承绪,武志昂.从药物警戒和药品不良反应监测制度探讨《药品管理法》尚待完善的有关内容[J].中国药物警戒,2009,6(2):65-68. 被引量:7
  • 10王晓燕,杨悦.欧盟新的药物警戒法规简介与启示[J].中国药物警戒,2013,10(7):396-399. 被引量:7

二级参考文献39

  • 1刘巍,陈易新.药品不良反应监测与药物警戒[J].中国执业药师,2008,5(8):18-20. 被引量:9
  • 2Tsintis P, La Mache E. CIOMS and ICH initiatives in pharmacovigilance and risk management: overview and implications[J]. Drug Saf,2004,27(8) :509-517.
  • 3Cobert BL. Manual of Drug Safety and Pharmacovigitance [ M ]. 2nd ed. Jones and Bartlett Publishers, 2007.
  • 4Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance [ J ]. Pharmacoepidemiol Drug Saf, 2003, 12(1) :17-29.
  • 5FDA. Challenges and Opportunities Report [ EB/OL]. http ://www. fda. gov/ScienceResearch/SpecialTopics/ Critical-Pathlnitiative/ CriticalPathOpportunitiesReports/ ucm077 262. htm , 2004/2010-06-02.
  • 6Di Masi JA, Hansen RW, Grabowski HG, et al. The price of innovation : new estimates of drug development costs [ J ]. J Health Econ ,2003,22 : 151-185.
  • 7Mann RD, Andrews EB. Pharmacovigilance [ M ]. 2nd ed. New Jersey: John Wiley & Sons, Ltd. , 2007.
  • 8Leiderman DB. Risk management of drug products and the U.S. Food and Drug Administration: evolution and context [ J ]. Drug Alcohol Depend,2009,105 ( Suppl 1 ) : S9-S13.
  • 9EMA. Guideline on Risk Management Systems for Medical Products for Human Use [ EB/OL ]. http ://www. ema. europa. eu/pdfs/human/euleg/9626805en, pdf, 2005/2010-06- 02.
  • 10ICH E2E. Pharmacovigilance Planning [ EB/OL ]. http :// www. ich. org/cache/compo/475 - 272 - 1. html # E2E, 2004/2010-06-02.

共引文献25

同被引文献145

引证文献16

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部